1.
Poikonen-Saksela P, Lindman H, Sverrisdottir A, Edlund P, Villman K, Tennvall Nittby L, et al. Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000–1. AO [Internet]. 2020 Jul. 2 [cited 2024 Nov. 27];59(7):825-32. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/24282